Skellefteå lasarett

Skellefteå 931 86

2 studies enrolling now · 5 studies all time

What they study most

Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction, Prevention of Stroke or Systemic Embolism, Transthyretin (TTR) Amyloid Cardiomyopathy, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction — Recruiting now
• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) — Enrolling by invitation
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
• Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early